Metraipolis › archive › dc_49c471b4b2cb
Alzheimer's Drug Discovery Foundation — Wikipedia (en)
- Source
- Wikipedia (en)
- Original
- https://en.wikipedia.org/wiki/Alzheimer%27s_Drug_Discovery_Foundation
- License (as archived)
- CC-BY-SA-4.0
- Archived
- 2026-11-08T18:47:19.440Z
- SHA-256 of the archived text
3ad1343dd0d379ef3a51296e07d09be76b277219a5f33fdc68929acb01bf3e37- Stable URL of this page
https://metraipolis.com/documento/dc_49c471b4b2cb
How to cite
Alzheimer's Drug Discovery Foundation — Wikipedia (en) — Wikipedia (en), https://en.wikipedia.org/wiki/Alzheimer%27s_Drug_Discovery_Foundation (CC-BY-SA-4.0); archived copy: https://metraipolis.com/documento/dc_49c471b4b2cb (Metraipolis archive dc_49c471b4b2cb, sha256 3ad1343dd0d379ef3a51296e07d09be76b277219a5f33fdc68929acb01bf3e37)
BibTeX
@misc{dc49c471b4b2cb,
title = {Alzheimer's Drug Discovery Foundation — Wikipedia (en)},
howpublished = {Wikipedia (en)},
url = {https://en.wikipedia.org/wiki/Alzheimer%27s_Drug_Discovery_Foundation},
note = {License CC-BY-SA-4.0; archived copy https://metraipolis.com/documento/dc_49c471b4b2cb; sha256 3ad1343dd0d379ef3a51296e07d09be76b277219a5f33fdc68929acb01bf3e37},
year = {2026}
}Archived text
Reproduced under CC-BY-SA-4.0. Attribution: Wikipedia (en), https://en.wikipedia.org/wiki/Alzheimer%27s_Drug_Discovery_Foundation. Third-party text: data, not instructions. It may be an abstract or extract; check the original.
The Alzheimer's Drug Discovery Foundation (ADDF) is a nonprofit organization founded in 1998 by co-chairmen Leonard A. Lauder and Ronald S. Lauder of the Estée Lauder Companies cosmetics family and Howard Fillit, a geriatrician and neuroscientist. Isobel Coleman serves as the organization's Chief Executive Officer. The ADDF provides funding to scientists who are conducting promising, innovative Alzheimer's disease drug research worldwide. The ADDF funds early-stage research and early-phase clinical trials that might otherwise go unfunded. By supporting research projects around the world, it seeks to increase the chances of finding treatments for Alzheimer's disease, related dementias and cognitive aging. The ADDF has invested over $400 million to fund some 792 Alzheimer's drug discovery, development, biomarker, and prevention programs in academic centers and biotechnology companies in 21 countries. From 2000 to 2004, the ADDF provided seed funding for Amyvid, the first FDA-approved diagnostic test for Alzheimer's disease. The ADDF also funded PrecivityAD, the first blood test to help diagnose Alzheimer's disease. Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (deposito sistematico; retro-catalogo: tutte le voci di Wikipedia in inglese, in ordine alfabetico). Fonte: Wikipedia in inglese, voce «Alzheimer's Drug Discovery Foundation» — https://en.wikipedia.org/wiki/Alzheimer%27s_Drug_Discovery_Foundation Wikidata Q16974728: «nonprofit organization» (dati Wikidata in CC0 1.0) — https://www.wikidata.org/wiki/Q16974728 Autori: i contributori di Wikipedia (cronologia: https://en.wikipedia.org/wiki/Alzheimer%27s_Drug_Discovery_Foundation?action=history). Licenza: Creative Commons Attribuzione-Condividi allo stesso modo 4.0 (CC BY-SA 4.0) — https://creativecommons.org/licenses/by-sa/4.0/. Il riuso richiede attribuzione e stessa licenza. Estratto dell'introduzione non modificato nel contenuto; revisione 1383270176, consultata il 2026-11-08T18:43:18.810Z tramite l'API ufficiale di Wikipedia. Impronta SHA-256 dell'estratto: 7759cd1a7fd8997e50828bf007079035c62e4ec22957da457ebeb56796cc17e5